Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🤫 Unfair Advantage: 10 bargain stocks found using this simple tool
See undervalued stocks
Marinus Pharmaceuticals Inc (MRNS)
Add to/Remove from a Portfolio
Add to Watchlist
0.541
-0.001
0.00%
02:30:09 - Closed. Currency in USD
After Hours
0.541
-0.000
-0.000%
4:39:05 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 574,563
- Bid/Ask: 0.000 / 0.000
- Day's Range: 0.538 - 0.545
Marinus Pharma
0.541
-0.001
0.00%
- Discussions
- Recent Sentiments
- User Rankings
MRNS User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Marinus Pharmaceuticals Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Ross Keiser | 2 | 2 | 2 | 100 | +157.92% |
| 2 | Tom Runesson | 7 | 7 | 3 | 42.86 | +146.95% |
| 3 | Marcel Jucker | 2 | 2 | 2 | 100 | +72.12% |
| 4 | Andreas Schatz | 1 | 1 | 1 | 100 | +55.05% |
| 5 | Asaf Ifrah | 2 | 2 | 1 | 50 | +55.03% |
| 6 | Ivan Dimitrov | 3 | 3 | 2 | 66.67 | +43.7% |
| 7 | Calvin Tay | 1 | 1 | 1 | 100 | +27.68% |
| 8 | Juanra Noya | 1 | 1 | 1 | 100 | +24.35% |
| 9 | Major Cl | 1 | 1 | 1 | 100 | +21.57% |
| 10 | Gregory McLeod | 1 | 1 | 1 | 100 | +21.53% |
| 11 | Errol Rackipov | 1 | 1 | 1 | 100 | +21.51% |
| 12 | Alex Yotov | 4 | 4 | 2 | 50 | +20.99% |
| 13 | Patricia Roger | 1 | 1 | 1 | 100 | +20.95% |
| 14 | Bill Adamuska | 1 | 1 | 1 | 100 | +18.31% |
| 15 | Estefania Juste | 1 | 0 | 0 | 0 | +16.96% |
| 16 | Ganesh Selvam | 1 | 1 | 1 | 100 | +16.71% |
| 17 | Samreet Brar | 1 | 1 | 1 | 100 | +16.19% |
| 18 | Javy Lopez | 1 | 1 | 1 | 100 | +14.91% |
| 19 | Mbusi Khumalo | 1 | 1 | 1 | 100 | +13.76% |
| 20 | Maurizio Gurgone | 1 | 1 | 1 | 100 | +13.57% |
| 21 | aa kk | 1 | 1 | 1 | 100 | +11.97% |
| 22 | Jose Miota | 1 | 1 | 1 | 100 | +11.97% |
| 23 | direttore limi | 1 | 1 | 1 | 100 | +8.54% |
| 24 | Miguel Fernández Mateos | 1 | 1 | 1 | 100 | +7.87% |
| 25 | João Silvestre | 1 | 1 | 1 | 100 | +6.95% |
| 26 | Владимир Бобачев | 1 | 1 | 1 | 100 | +5.71% |
| 27 | Giampaolo Bozzi | 1 | 1 | 1 | 100 | +5.22% |
| 28 | Robbert Kuipers | 1 | 1 | 1 | 100 | +4.79% |
| 29 | Ivica Maurovic | 1 | 1 | 1 | 100 | +4.76% |
| 30 | Anton Solovyev | 2 | 2 | 1 | 50 | +4.37% |
| 31 | Umesh Bangur | 1 | 1 | 1 | 100 | +4.01% |
| 32 | Stan Caudron | 1 | 1 | 1 | 100 | +1.37% |
| 33 | jm landaluce | 1 | 1 | 1 | 100 | +1.02% |
| 34 | djonivi ntchou | 1 | 1 | 0 | 0 | 0% |
| 35 | aleksej kotlyer | 1 | 1 | 0 | 0 | 0% |
| 36 | Casey Shroff | 1 | 1 | 0 | 0 | -0.7% |
| 37 | владимир рад | 1 | 1 | 0 | 0 | -1.07% |
| 38 | Mutarid Almutarid | 1 | 1 | 0 | 0 | -2.5% |
| 39 | Wojciech Zimnicki | 1 | 1 | 0 | 0 | -2.68% |
| 40 | Cristian Tatulescu | 2 | 2 | 1 | 50 | -2.87% |
| 41 | Ilan Abras | 1 | 1 | 0 | 0 | -6.02% |
| 42 | valerij andrijchuk | 2 | 2 | 1 | 50 | -6.26% |
| 43 | Jubin Thomas | 1 | 1 | 0 | 0 | -6.4% |
| 44 | Young Hwan Kim | 1 | 0 | 0 | 0 | -7.09% |
| 45 | Dvir Bach | 1 | 1 | 0 | 0 | -8.31% |
| 46 | David Ohana | 1 | 1 | 0 | 0 | -8.47% |
| 47 | Austin Pinnell | 1 | 1 | 0 | 0 | -8.59% |
| 48 | Robbert Kuipers | 1 | 1 | 0 | 0 | -8.59% |
| 49 | Ronald Perez | 1 | 1 | 0 | 0 | -9.33% |
| 50 | Riki Sacco | 1 | 1 | 0 | 0 | -9.35% |
Write your thoughts about Marinus Pharmaceuticals Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review